XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Statement of Comprehensive Income [Abstract]    
Net income (loss) $ 22,228,087 $ (33,309,533)
Other comprehensive loss:    
Available for sale securities - net unrealized loss (27,978) (486)
Total other comprehensive loss (27,978) (486)
Comprehensive income (loss) 22,200,109 (33,310,019)
Comprehensive loss attributable to noncontrolling interests (750,613) (653,214)
Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders $ 22,950,722 $ (32,656,805)